Anixa Biosciences logo

Anixa BiosciencesNASDAQ: ANIX

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

07 October 1983

Next earnings report:

12 March 2025

Last dividends:

N/A

Next dividends:

N/A
$106.19 M
-43%vs. 3y high
46%vs. sector
-vs. 3y high
-vs. sector
-27%vs. 3y high
81%vs. sector
-vs. 3y high
-vs. sector

Price

after hours | 103 min ago
$3.30+$0.18(+5.77%)

Dividend

No data over the past 3 years

Analysts recommendations

Institutional Ownership

ANIX Latest News

Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024
prnewswire.com31 October 2024 Sentiment: POSITIVE

SAN JOSE, Calif. , Oct. 31, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced its presentation at the Sidoti Micro-Cap Virtual Conference, taking place November 13-14, 2024.

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine
prnewswire.com24 September 2024 Sentiment: POSITIVE

Announces focus on therapeutic approach; resulting in a faster and more cost-effective path to approval SAN JOSE, Calif. , Sept. 24, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced its strategic plan for a Phase 2 study for its breast cancer vaccine.

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
prnewswire.com17 July 2024 Sentiment: POSITIVE

SAN JOSE, Calif. , July 17, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its collaborator, Cleveland Clinic, has received a "Decision to Grant" notice from the Japan Patent Office (JPO) for the patent application titled "Vaccine Adjuvants and Formulations.

Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
PRNewsWire30 April 2024 Sentiment: POSITIVE

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company specializing in cancer treatment and prevention, will be participating in the Sidoti Micro-Cap Virtual Conference on May 8-9, 2024.

3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023
InvestorPlace11 December 2023 Sentiment: POSITIVE

Some of the most explosive opportunities can be found in biotech stocks.  Look at CRISPR Therapeutics (NASDAQ: CRSP ), for example.

FATE Q3 Earnings Beat on Lower Expenses, Revenues Fall Y/Y
Zacks Investment Research09 November 2023 Sentiment: POSITIVE

FATE reports better-than-expected third-quarter 2023 financial results, driven by lower operating expenses. The stock rises about 5% in the after-market hours.

ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research21 September 2023 Sentiment: POSITIVE

ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

The 3 Most Undervalued Cheap Stocks to Buy in September 2023
InvestorPlace11 September 2023 Sentiment: POSITIVE

The United States Treasury Secretary, Janet Yellen, recently expressed her confidence in the economy's ability to recover from the recession without causing significant harm to the job market or sparking excessive inflation. She believes that the United States will successfully navigate this economic challenge, maintaining control over consumer-price increases.This is leading to many investors considering cheap stocks to buy.

What Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stock
Zacks Investment Research22 June 2023 Sentiment: POSITIVE

ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Anixa Biosciences (ANIX) Outperforming Other Medical Stocks This Year?
Zacks Investment Research25 April 2023 Sentiment: POSITIVE

Here is how ANIXA BIOSCIENCES INC (ANIX) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year.

What type of business is Anixa Biosciences?

Anixa Biosciences, Inc., a clinical-stage biotechnology company, focuses on the treatment and prevention of cancer. Its therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR- T, known as chimeric endocrine receptor T-cell (CER-T) technology. The company's vaccine portfolio includes a novel vaccine being developed in collaboration with Cleveland Clinic to prevent breast cancer – primarily triple negative breast cancer (TNBC), the lethal form of the disease, as well as a vaccine to prevent ovarian cancer. Its vaccine technologies focus on immunizing against retired proteins that found to be expressed in certain forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

What sector is Anixa Biosciences in?

Anixa Biosciences is in the Healthcare sector

What industry is Anixa Biosciences in?

Anixa Biosciences is in the Biotechnology industry

What country is Anixa Biosciences from?

Anixa Biosciences is headquartered in United States

When did Anixa Biosciences go public?

Anixa Biosciences initial public offering (IPO) was on 07 October 1983

What is Anixa Biosciences website?

https://www.anixa.com

Is Anixa Biosciences in the S&P 500?

No, Anixa Biosciences is not included in the S&P 500 index

Is Anixa Biosciences in the NASDAQ 100?

No, Anixa Biosciences is not included in the NASDAQ 100 index

Is Anixa Biosciences in the Dow Jones?

No, Anixa Biosciences is not included in the Dow Jones index

When was Anixa Biosciences the previous earnings report?

No data

When does Anixa Biosciences earnings report?

The next expected earnings date for Anixa Biosciences is 12 March 2025